SEC EDGAR · Insider purchase
SOPH: Muken Ross reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow SOPH- Became public
- Nov 9, 2026, 4:05 PM EST
- Event / period date
- Nov 6, 2026
- Collected
- Nov 9, 2026, 4:16 PM EST
Why this is connected
This filing identifies SOPHiA GENETICS SA as the issuer of the security. The company's SEC identifier connects it to SOPH.
Reported transactions
Muken Ross (Chief Executive Officer)
20,000 shares · Ordinary Shares
Nov 6, 2026 · $6.8594 per share
Value calculated from the reported shares and prices: $137,188.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-06</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0001840706</issuerCik>
<issuerName>SOPHiA GENETICS SA</issuerName>
<issuerTradingSymbol>SOPH</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0002005463</rptOwnerCik>
<rptOwnerName>Muken Ross</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>C/O SOPHIA GENETICS INC.</rptOwnerStreet1>
<rptOwnerStreet2>401 PARK DRIVE, FLOOR 5</rptOwnerStreet2>
<rptOwnerCity>BOSTON</rptOwnerCity>
<rptOwnerState>MA</rptOwnerState>
<rptOwnerZipCode>02215</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>1</isDirector>
<isOfficer>1</isOfficer>
<isTenPercentOwner>0</isTenPercentOwner>
<isOther>0</isOther>
<officerTitle>Chief Executive Officer</officerTitle>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Ordinary Shares</value>
</securityTitle>
<transactionDate>
<value>2026-11-06</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value>20000</value>
</transactionShares>
<transactionPricePerShare>
<value>6.8594</value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>680391</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<derivativeTable></derivativeTable>
<footnotes>
<footnote id="F1">The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.70 to $7.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.</footnote>
</footnotes>
<remarks></remarks>
<ownerSignature>
<signatureName>/s/ Elimara Brunetto as Attorney-in-fact for Ross Muken</signatureName>
<signatureDate>2026-11-09</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.